Development of this evidence summary

Development of this evidence summary

The evidence summary: process guide (2017) sets out the process NICE uses to select topics for evidence summaries and details how the summaries are developed, quality assured and approved for publication.

Expert advisers

Professor Peter Calverley, professor of respiratory medicine, University of Liverpool.

Dr Anastasios Lekkas, consultant respiratory physician, University Hospital Southampton NHS Foundation Trust.

Dr Sarah Scrivener, consultant respiratory physician, Portsmouth Hospitals NHS Trust.

Professor Jadwiga Wedzicha, professor of respiratory medicine, Imperial College London.

Declarations of interest

Peter Calverley receives payments from Boehringer Ingelheim for advice on clinical trial design and conduct, and speaking at meetings. He has also received an honorarium from GSK for work on a study.

Anastasios Lekkas: no relevant interests declared.

Sarah Scrivener: no relevant interests declared.

Jadwiga Wedzicha has received research grants for her institution from GSK, Astra Zeneca, Novartis and Boehringer Ingelheim.

About this evidence summary

Evidence summaries provide a summary of the best available published evidence for selected new medicines, unlicensed medicines or off-label use of licensed medicines.

The summaries assess the strengths and weaknesses of the best available evidence to inform health professionals and commissioners' decision-making.

This summary is not NICE guidance.

ISBN: 978-1-4731-2933-7